Group One Trading, L.P. X Biotech Inc. Transaction History

Group One Trading, L.P.

  • $2.54 Billion
  • Q4 2024

A detailed history of Group One Trading, L.P. transactions in X Biotech Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 7,500 shares of XBIT stock, worth $24,675. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,500
Holding current value
$24,675
% of portfolio
0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$3.8 - $8.25 $28,500 - $61,875
7,500 New
7,500 $29,000
Q3 2023

Nov 09, 2023
BUY
$4.02 - $5.81 $6,319 - $9,133
1,572 Added 946.99%
1,738 $7,000
Q2 2023

Aug 09, 2023
BUY
$3.06 - $6.38 $507 - $1,059
166 New
166 $0
Q2 2022

Aug 11, 2022
BUY
$5.13 - $9.2 $17,955 - $32,199
3,500 Added 700.0%
4,000 $23,000
Q1 2022

May 12, 2022
BUY
$8.64 - $11.71 $4,320 - $5,855
500 New
500 $4,000
Q4 2021

Feb 11, 2022
SELL
$10.95 - $16.07 $22,162 - $32,525
-2,024 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$12.95 - $18.24 $26,210 - $36,917
2,024 New
2,024 $26,000
Q2 2021

Aug 10, 2021
SELL
$15.83 - $17.84 $205,774 - $231,902
-12,999 Closed
0 $0
Q1 2021

May 12, 2021
SELL
$15.92 - $20.3 $115,101 - $146,769
-7,230 Reduced 35.74%
12,999 $223,000
Q4 2020

Feb 10, 2021
SELL
$15.65 - $19.92 $71,990 - $91,632
-4,600 Reduced 18.53%
20,229 $317,000
Q3 2020

Nov 12, 2020
BUY
$13.97 - $21.16 $32,592 - $49,366
2,333 Added 10.37%
24,829 $474,000
Q2 2020

Aug 13, 2020
BUY
$10.39 - $16.07 $97,375 - $150,608
9,372 Added 71.41%
22,496 $308,000
Q1 2020

May 13, 2020
BUY
$8.89 - $24.94 $110,351 - $309,580
12,413 Added 1745.85%
13,124 $139,000
Q4 2019

Feb 10, 2020
SELL
$8.33 - $19.95 $101,542 - $243,190
-12,190 Reduced 94.49%
711 $13,000
Q3 2019

Nov 12, 2019
BUY
$6.86 - $10.46 $43,869 - $66,891
6,395 Added 98.29%
12,901 $135,000
Q2 2019

Aug 09, 2019
BUY
$6.99 - $11.27 $15,405 - $24,839
2,204 Added 51.23%
6,506 $49,000
Q1 2019

May 13, 2019
SELL
$5.05 - $11.62 $70,846 - $163,016
-14,029 Reduced 76.53%
4,302 $47,000
Q4 2018

Feb 06, 2019
BUY
$3.22 - $6.27 $3,928 - $7,649
1,220 Added 7.13%
18,331 $93,000
Q3 2018

Nov 08, 2018
SELL
$2.31 - $4.69 $27,791 - $56,425
-12,031 Reduced 41.28%
17,111 $54,000
Q2 2018

Aug 14, 2018
BUY
$4.04 - $5.13 $54,043 - $68,624
13,377 Added 84.85%
29,142 $131,000
Q1 2018

May 11, 2018
SELL
$3.92 - $5.35 $25,872 - $35,310
-6,600 Reduced 29.51%
15,765 $84,000
Q4 2017

Feb 09, 2018
SELL
$3.9 - $4.66 $103,763 - $123,983
-26,606 Reduced 54.33%
22,365 $88,000
Q3 2017

Nov 15, 2017
BUY
$4.14 - $5.12 $167,222 - $206,807
40,392 Added 470.82%
48,971 $214,000
Q2 2017

Aug 14, 2017
BUY
N/A
8,579
8,579 $40,000

Others Institutions Holding XBIT

# of Institutions
54
Shares Held
4.7M
Call Options Held
200
Put Options Held
12.8K
View Full List

About XBiotech Inc.

XBIT Quotes by TradingView
  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $100M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email